Findings of European expert meeting on faster access to innovative medicines
The first steps have been taken towards new market authorisation and reimbursement procedures for innovative medicines. Over 100 experts from across Europe discussed the topic in Amsterdam at the invitation of the Minister of Health, Welfare and Sport, Edith Schippers.
Increasing availability of innovative medicines
More and more innovative medicines are becoming available. This is good news for the patients who need them. However, since these medicines are often intended for a small group of people, there is not always enough research data available. This means it takes longer to determine the efficacy, safety and added value of these drugs. And the longer that takes, the longer patients have to wait until they can obtain the new drugs.
Accelerating market authorisation
During the Dutch EU Presidency, Ms Schippers would like to speed up market authorisation procedures for new medicines. ‘Here in Europe we need to look at how we can get these medicines to patients who’ve been waiting for them as soon as possible, without any safety risks,’ said the minister. ‘This must go hand in hand with affordability. After all, what’s the point of authorising a medicine if it’s completely unaffordable? Innovative medicines require effective collaboration on market authorisation and reimbursement policies at an early stage. At present, there is insufficient cooperation between the authorities responsible for these at both national and international level.’
Three key questions
The experts looked at the various methods for accelerated or conditional market authorisation and ways for different countries and authorities to share research data with each other. They examined three questions. What products need to be made available more quickly? What conditions should we place on this? And what procedures need to be better aligned?
Broad agreement on urgency
The discussions revealed that the experts agree on the importance of taking joint action. A future-proof EU system will require both an updated market authorisation policy and new reimbursement methods. More effective collaboration between the authorities responsible for market authorisation and reimbursement is crucial to fast, affordable access to innovative medicines.
The findings of the conference will be addressed at the health council meeting in April, when health ministers from the 28 EU member states will discuss the EU’s policy on medicines.
Latest News from
NextGenerationEU: European Commission disburses €271 million in pre-financing to Finland21/01/2022 15:25:00
The European Commission has today disbursed €271 million to Finland in pre-financing, equivalent to 13% of the country's financial allocation under the Recovery and Resilience Facility (RRF).
EU challenges Russian export restrictions on wood at WTO21/01/2022 13:25:00
Today, the EU is requesting consultations with Russia at the World Trade Organization (WTO) concerning export restrictions placed by Russia on wood products.
‘State of the World' Special Address by President von der Leyen at the World Economic Forum, via videoconference21/01/2022 11:33:00
‘State of the World' Special Address given yesterday by President von der Leyen at the World Economic Forum, via videoconference.
Protecting consumers from misleading reviews: 55% of screened websites violate EU law21/01/2022 10:38:00
The European Commission and national consumer protection authorities yesterday released the results of an EU-wide website screening (“sweep”) on online consumer reviews.
Speech by President von der Leyen at the European Women on Boards' Gender Diversity Award21/01/2022 09:25:00
Speech given yesterday by President von der Leyen at the European Women on Boards' Gender Diversity Award.
Speech by Executive Vice-President Vestager on the Digital Services Act20/01/2022 16:33:00
Speech given yesterday by Executive Vice-President Vestager on the Digital Services Act.
European Globalisation Adjustment Fund: €2.8 million to support dismissed workers in the Spanish car industry20/01/2022 15:25:00
Today, the European Commission proposes to support 450 workers who lost their jobs in the car industry in the Spanish region of Catalonia with €2.8 million from the European Globalisation Adjustment Fund for Displaced Workers (EGF).
Intellectual property: Statement by EU Internal Market Commissioner Thierry Breton welcoming the provisional application of the Unitary Patent20/01/2022 14:33:00
Intellectual property: Statement given yesterday by EU Internal Market Commissioner Thierry Breton welcoming the provisional application of the Unitary Patent.
Speech by Commissioner Breton on the Digital Services Act20/01/2022 13:25:00
Speech given yesterday by Commissioner Breton on the Digital Services Act.
EU Cohesion policy: Almost €385.5 million from the EU Solidarity Fund to 19 countries to tackle the coronavirus health emergency20/01/2022 12:38:00
The Commission completed the payments of the EU Solidarity Fund (EUSF) assistance to tackle the coronavirus health emergency to 19 countries for a total amount of almost €385.5 million.